CT55 is also a member of the cancer testicular antigen family, and studies have found that CT55 deficiency inhibits the NF-KB signaling pathway, thereby attenuating colitis-associated cancers (Zhao et al., 2019). This evidence concerns the gene NFKB1 and cancer.